1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting(
- Contribution to conference › Poster
- 2024
-
Mark
Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer
(
- Contribution to journal › Article
-
Mark
Tru-cut biopsy in gynecological cancer: adequacy, accuracy, safety and clinical applicability
2024) 34th World Congress on Ultrasound in Obstetrics and Gynecology In Ultrasound in Obstetrics & Gynecology 64(S1). p.65-65(
- Contribution to journal › Published meeting abstract
- 2023
-
Mark
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
(
- Contribution to journal › Article
- 2022
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
(
- Contribution to journal › Article
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
(
- Contribution to journal › Published meeting abstract
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”(
- Contribution to conference › Poster
- 2021
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
(
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
(
- Contribution to journal › Article